The company continues to go from strength to strength, with year on year growth of 20% in 2013, and their 2014 figures due to exceed this. Their precision engineered, patented split valve technology has become a global pharmaceutical industry standard for high containment batch transfers.
The development of Split Butterfly Valve technology has increased its suitability for a wider range of industry applications where product flow, yield and sterility issues are also prominent.
As an ISO9001 accredited business, ChargePoint Technology’s processes adhere to the latest international guidelines for Good Manufacturing Practice (GMP). With on-site research and development, engineering and manufacturing operations, they design, produce and test each product using cutting edge technology to ensure each component is of the highest quality.
Recently winning a raft of awards including the Queens Award for Enterprise, Business of the Year and Product of the Year, they have been recognised for their achievements, quality and innovation.
With offices in the UK, US and Hong Kong, and a global network of business partners, ChargePoint Technology is well placed to increase its market penetration in different geographical locations throughout 2015. They are also planning to launch several new products to add to their current range, and anticipate continued growth and expansion.
